Table 1.
Demographic characteristics of donor population and blood product collections in Georgia, 2015–2017
| Overall n (%)* | Blood Donation Year | |||
|---|---|---|---|---|
| 2015 | 2016 | 2017 | ||
| Donations | 251,428 | 79,191 | 84,503 | 87,734 |
| Unique Donors | 112,093 | 48,634 | 50,893 | 51,689 |
| Sex† | ||||
| Female | 35,137 (31.5) | 14,494 (29.9) | 15,956 (31.6) | 16,330 (31.6) |
| Male | 76,389 (68.5) | 33,931 (70.1) | 34,592 (68.4) | 35,277 (68.4) |
| Age (years) | ||||
| 18–29 | 50,098 (44.7) | 22,584 (46.4) | 22,668 (44.5) | 22,959 (44.4) |
| 30–39 | 30,492 (27.2) | 12,659 (26.0) | 13,651 (26.8) | 13,877 (26.8) |
| 40–49 | 19,794 (17.7) | 8,170 (16.8) | 9,015 (17.7) | 9,384 (18.2) |
| 50+ | 11,709 (10.4) | 5,221 (10.7) | 5,559 (10.9) | 5,469 (10.6) |
| Region of Donation | ||||
| Tbilisi | 61,457 (54.8) | 28,289 (58.2) | 28,196 (55.4) | 27,704 (53.6) |
| Adjara | 11,572 (10.3) | 3,075 (6.3) | 4,594 (9.0) | 5,575 (10.8) |
| Imereti | 16,935 (15.1) | 6,902 (14.2) | 7,240 (14.2) | 6,639 (12.8) |
| Kvemo Kartli | 12,919 (11.5) | 5,687 (11.7) | 6,581 (12.9) | 7,396 (14.3) |
| Samegrelo | 4,273 (3.8) | 1,655 (3.4) | 1,681 (3.3) | 1,585 (3.1) |
| Shida Kartli | 4,937 (4.4) | 3,026 (6.2) | 2,601 (5.1) | 2,790 (5.4) |
| Donor Type | ||||
| Repeat | 55,116 (49.2) | 30,267 (62.2) | 31,822 (62.5) | 32,071 (62.0) |
| First Time | 56,977 (50.8) | 18,367 (37.8) | 19,071 (37.5) | 19,618 (38.0) |
| Remuneration | ||||
| Volunteer | 39,882 (35.6) | 13,747 (28.3) | 17,703 (34.8) | 16,573 (32.1) |
| Paid | 30,806 (27.5) | 18,705 (38.5) | 18,640 (36.6) | 16,964 (32.8) |
| Replacement | 26,570 (23.7) | 9,088 (18.7) | 11,003 (21.6) | 9,896 (19.1) |
| Missing | 14,835 (13.2) | 7,094 (14.6) | 3,547 (7.0) | 8,256 (16) |
| HBsAg Results | ||||
| - | 110,165 (98.3) | 47,892 (98.5) | 50,280 (98.8) | 51,115 (98.9) |
| + | 1,928 (1.7) | 742 (1.5) | 613 (1.2) | 574 (1.1) |
| Anti-HCV Results | ||||
| - | 109,348 (97.6) | 47,495 (97.7) | 50,011 (98.3) | 50,962 (98.6) |
| + | 2,745 (2.4) | 1,139 (2.3) | 882 (1.7) | 727 (1.4) |
| HIV | ||||
| - | 111,862 (99.8) | 48,559 (99.8) | 50,807 (99.8) | 51,619 (99.9) |
| + | 231 (0.2) | 75 (0.2) | 86 (0.2) | 70 (0.1) |
| T.Pallidum | ||||
| - | 110,831 (98.9) | 48,122 (98.9) | 50,519 (99.3) | 51,313 (99.3) |
| + | 1,262 (1.1) | 512 (1.1) | 374 (0.7) | 376 (0.7) |
*
The overall 3 years, 2015‐2017, results shown represent cumulative infection prevalence rates over the 3 years period
†
Missing values not shown
anti‐HCV = hepatitis C virus antibody; HBsAg = hepatitis B surface antigen; HIV = human immunodeficiency virus.